Pulmonx (LUNG) Free Cash Flow Growth (3y) (2022 - 2025)
Pulmonx (LUNG) Free Cash Flow Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 9.23% |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.09% |
| Jun 30, 2025 | 26.64% |
| Mar 31, 2025 | 4.47% |
| Dec 31, 2024 | 16.73% |
| Sep 30, 2024 | 8.41% |
| Jun 30, 2024 | 22.29% |
| Mar 31, 2024 | -7.21% |
| Dec 31, 2023 | -3.10% |
| Sep 30, 2023 | -11.70% |
| Jun 30, 2023 | -0.57% |
| Mar 31, 2023 | -10.88% |
| Dec 31, 2022 | -38.92% |